Universe Pharma Tirzepatide

Tirzepatide is a medication primarily used for the treatment of type 2 diabetes and chronic weight management. The brand displayed, Universe Pharma, is a company often associated with the production and distribution of pharmaceutical peptides and health supplements within the Brazilian market.

While the active ingredient Tirzepatide was originally developed by the American pharmaceutical giant Eli Lilly and Company (marketed as Mounjaro or Zepbound), products from Universe Pharma represent compounded or generic versions distributed by local laboratories. The manufacturing of such vials typically occurs in Brazil to serve the local demand for specialized medications under the Universe Pharma brand.